Moderna’s SARS-CoV-2 Vaccine Phase I Data
So, long story short: encouraging first phase, with a whole lot of caveats, it will need to wait on phase 2 and phase 3 even if everything goes well, there are some negative reactions (but in this small group nothing too serious), and it would take at least two doses and the effect starts to fade after a couple months (which doesn&#x27;t mean it would go away entirely).  Plus we really only know that there was _some_ response, not that it would protect you in the way we normally expect a vaccine to.<p>In other words, long story short, probably not this year.